This filing is purely administrative — no trading signal. Monitor upcoming ASX announcements for any new option grants or capital structure changes that could affect dilution.
Price Chart
Executive Summary
Radiopharm Theranostics filed a 6-K with the ASX reporting that four directors (Riccardo Canevari, Paul Hopper, Ian Turner, Hester Larkin) each experienced the expiry of listed options on August 24, 2026. The filings are purely administrative notifications of option expiry — no new grants, exercises, or open-market trades occurred. This is a routine disclosure with no material financial or operational impact.
Key Facts
- Four directors reported expiry of listed options on August 24, 2026.
- Riccardo Canevari: 1,875,000 options expired; post-expiry holds 183,412,299 options.
- Paul Hopper: 27,500,000 options expired; post-expiry holds 35,159,518 options.
- Ian Turner: 1,875,000 options expired (1,125,000 direct + 750,000 indirect); post-expiry holds 22,027,348 options.
- Hester Larkin: 275,000 options expired; post-expiry holds 9,900,002 options.
- No consideration was received for any of the expired options.
- No open-market trades, exercises, or new grants were reported.
Financial Impact
No financial impact — option expiry is a scheduled event with no cash consideration.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (RADX) — Batch item 1 | 0001213900-26-094127 |
| Document: 0001213900-26-094127-index-headers.html | 0001213900-26-094127 |
| Document: 0001213900-26-094127-index.html | 0001213900-26-094127 |
| Document: 0001213900-26-094127.txt | 0001213900-26-094127 |
| 6-K Filing (RADX) — Batch item 5 | 0001213900-26-094127 |
| Document: 0001213900-26-094127-index-headers.html | 0001213900-26-094127 |
| Document: 0001213900-26-094127-index.html | 0001213900-26-094127 |
| Document: 0001213900-26-094127.txt | 0001213900-26-094127 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $0.9485 | awaiting T+5 | — | $0.9960 (+5.01%) |
Oct 20, 2026 6d ago | 6-K | $0.9900 | awaiting T+5 | — | $0.9960 (+0.61%) |
Oct 14, 2026 12d ago | SC 13G | $1.08 $0.9500 | ▼ −12.04% | ▼ −11.02% | $0.9960 (−7.78%) |
Oct 5, 2026 21d ago | 6-K | $1.27 $1.11 | ▼ −12.60% | ▼ −13.02% | $0.9960 (−21.57%) |
Oct 1, 2026 25d ago | 6-K | $1.48 $1.11 | ▼ −25.00% | ▼ −26.30% | $0.9960 (−32.70%) |
Sep 30, 2026 26d ago | 6-K | $1.62 $1.15 | ▼ −29.01% | ▼ −30.93% | $0.9960 (−38.52%) |
Sep 24, 2026 4w ago | EFFECT | $1.57 $1.48 | ▲ +5.85% | ▲ +5.43% | $0.9960 (+36.64%) |
Sep 22, 2026 4w ago | 6-K | $1.65 $1.52 | ▼ −7.88% | ▼ −6.69% | $0.9960 (−39.64%) |
Sep 14, 2026 6w ago | 6-K | $2.01 $1.61 | ▼ −19.90% | ▼ −20.01% | $0.9960 (−50.45%) |
Sep 11, 2026 6w ago | 6-K | $1.98 $1.65 | ▼ −16.67% | ▼ −16.45% | $0.9960 (−49.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers